If the cells you would like to access are currently listed as unavailable or you are ordering from outside of Europe please get in touch via Contact@EBiSC.org.


iPSC derived cells

Not-for-profit fee: £1127 per vial
Immediately available for distribution*
*Once all legal and processing details completed
Time: 7 days post-thaw
Magnification: 40x
Description: Cryopreserved EBiSC-NEUR1 cells were thawed, cultured on Poly-Ornithine / Laminin and immunostained after 7 days for beta-III-tubulin (TUBB3, magenta) and DAPI (blue).
Time: 7 days post-thaw
Magnification: 10X
Description: EBiSC-NEUR1 cells form neurite networks after thaw.
A Product Information Pack contains information about a product including any specific third party obligations relating to, for example, licensing obligations or the donor consent which affect the use of the derived product.

You will need to complete an EBiSC Access and Use Agreement (EAUA) before purchasing your cell line.
This Certificate of Analysis is of the latest released batch. We are publishing it for reference purpose, but we cannot guarantee batch specific delivery.
This user protocol is of the latest released batch. We are publishing it for reference purpose, but we cannot guarantee batch specific delivery.
Catalogue No. EBiSC-NEUR1
Product Type iPSC-derived neurons
iPSC Product Name EBiSC-NEUR1
iPSC Product Cell Type Neuron
Source iPSC Line Name BIONi010-C-13
Donor Disease Status Normal
Genetic Modification Description: DOX inducible NEUROG2
Format 2ml cryovial
Cell Number 4x10^6
Morphology Description EBiSC-NEUR1 neurons extend multiple processes after thaw and form neurite networks


EBiSC-NEUR1 cells are early neurons derived from human induced pluripotent stem cells using a doxycycline-inducible NGN2 expression system. The transcription-factor based differentiation approach accelerates neuron maturation while reducing cell culture variability. When thawed and cultured according to the instructions in the User protocol, the EBiSC-NEUR1 neurons express classical pan-neuronal markers such as beta-III-tubulin (TUBB3) and microtubule-associated protein 2 (MAP2) and form neurite networks. EBiSC-NEUR1 cultures exert a great homogeneity with low batch-to-batch variability providing an ideal starting point for diverse co-culture approaches as well as large-scale assays and high-throughput drug screenings.
Quality control is performed prior to release and includes sterility testing, morphological assessment, as well as flow cytometric and immunochemical analyses for the expression of neuronal markers.